AquaBounty GMO salmon was going to be the future of fish — and the future for one Ohio village that offered incentives to ...
Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...
About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising ...
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
SAN DIEGO and CALGARY, AB, Feb. 14, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ ... that it received a delinquency notification letter (the "Notice") from the Listing Qualifications ...
Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them ...
Grey Wolfe in West London hones in on hyper-personalization of wellness programs. and puts a premium on unparalleled privacy.
About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising ...